文献速递结核与非结核分枝杆菌艾滋病与性传播感染

乌克兰高耐药结核负担地区完成异烟肼预防性治疗的HIV感染者结核发病率较低:一项回顾性队列研究

Lower Tuberculosis Incidence Among People With HIV Who Completed Isoniazid Preventive Therapy in Ukraine, a High-Burden Multidrug-Resistant Tuberculosis Setting: A Retrospective Cohort Study.
PubMed 文献 · Clin Infect Dis · 2025-01-01

该回顾性队列研究分析乌克兰2018—2022年全国监测数据,比较完成异烟肼预防性治疗(IPT)与未接受IPT的HIV感染者结核发病率。完成IPT组结核发病率为1.01例/100人年,未IPT组为1.91例/100人年(aIRR 1.99);在病毒学抑制者中未IPT组结核发病率仍较高(aIRR 1.38)。作者认为完成IPT作为公共卫生干预可显著降低HIV感染者结核发病率。

要点

  • 完成IPT组结核发病率为1.01例/100人年,未IPT组为1.91例/100人年,aIRR为1.99。
  • 病毒学抑制的HIV感染者中,未IPT者结核发病率高于完成IPT者,aIRR为1.38。
  • 作者认为在高耐药结核负担地区完成IPT作为公共卫生干预可显著降低结核发病率。

核心结论

  • 完成IPT作为公共卫生干预的一部分可显著降低HIV感染者结核发病率,即使在高耐药结核负担地区和病毒学抑制者中亦然。

研究设计与样本

  • 回顾性队列研究,分析乌克兰2018—2022年收集的HIV和结核国家监测数据,纳入131 755名HIV感染者。
  • 完成IPT定义为接受治疗≥146天(n=40 733),无IPT定义为治疗<28天(n=91 022)。
  • 使用泊松回归调整与IPT接受和结核发病率相关的协变量,对结核发病率和死亡进行建模。

主要发现

  • 131 755名符合纳入标准的HIV感染者中,9089人(5.5%)死亡。
  • 未调整结核发病率在无IPT组为1.91例/100人年,在完成IPT组为1.01例/100人年(调整发病率比[aIRR]为1.99)。
  • 结核病例中耐多药结核在完成IPT组占29.1%,在无IPT组占30.7%。
  • 在病毒学抑制的HIV感染者中,无IPT者结核发病率高于完成IPT者(aIRR为1.38)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Evidence shows that isoniazid preventive therapy (IPT) reduces tuberculosis (TB) incidence among people with human immunodeficiency virus (HIV) with additive benefit beyond antiretroviral therapy alone, but its effectiveness in settings with high multidrug-resistant TB (MDR-TB) burden is unclear. We assessed the relationship between IPT and TB incidence among people with HIV (PWH) in Ukraine, a high-burden (32.6%) MDR-TB setting, and whether its effectiveness is maintained among virologically suppressed persons. METHODS: We analyzed national surveillance data for HIV and TB collected between 2018 and 2022. Complete IPT (n = 40 733) was defined as receipt of ≥146 days of therapy and no IPT (n = 91 022) as <28 days of therapy. We modeled TB incidence and death using Poisson regression adjusting for covariates related to receipt of IPT and TB incidence. The secondary outcome was multidrug resistance, and sensitivity analyses explored the influence of virologic suppression. RESULTS: Of 131 755 PWH who met inclusion criteria, 9089 (5.5%) died. Unadjusted TB incidence was 1.91 cases per 100 person-years in the No IPT group and 1.01 cases per 100 person-years in the Complete IPT group (adjusted incidence rate ratio [aIRR], 1.99). MDR-TB occurred in 29.1% and 30.7% of TB cases in the Complete and No IPT groups, respectively. Among virologically suppressed PWH, persons with no IPT had a higher TB incidence (aIRR, 1.38) than those who completed IPT. CONCLUSIONS: Completing IPT as part of a public health intervention can significantly reduce TB incidence among PWH, even in settings with high-burden MDR-TB and among the virologically suppressed.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Sodeke O, Shah NS, Pals S, et al. Lower Tuberculosis Incidence Among People With HIV Who Completed Isoniazid Preventive Therapy in Ukraine, a High-Burden Multidrug-Resistant Tuberculosis Setting: A Retrospective Cohort Study. Clin Infect Dis. 2025. PMID: 40099906. doi:10.1093/cid/ciaf069

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。